How long rhabdomyosarcoma (RMS) patients live varies, significantly influenced by factors such as age and how well the cancer responds to treatment.
According to available data, survival rates differ between children and adults:
- The overall 5-year survival rate for children with RMS is approximately 70% (Reference: 02-Mar-2023).
- Survival rates for adults with RMS are generally lower than those for children (Reference: 02-Mar-2023).
Other factors influencing survival rates include:
- Stage of Cancer: The extent and spread of the cancer.
- Tumor Location: Where the tumor is located in the body.
- RMS Subtype: Specific type of rhabdomyosarcoma.
- Response to Therapy: How well the cancer responds to treatments such as chemotherapy, radiation, and surgery.
| Patient Group | 5-Year Survival Rate (Approximate) |
|---|---|
| Children | 70% |
| Adults | Lower than Children |
It's crucial to consult with healthcare professionals for personalized prognoses and treatment plans.
